HY-100064-50mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
HY-100064-1mL
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-100064S-1mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib-d8
|
|
Cancer-Kinase/protease
|
|
HY-100064S-5mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib-d8
|
|
Cancer-Kinase/protease
|
|
HY-14250-10mg
|
MedChemexpress LLC
|
PF-998425 [CAS 1076225-27-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-14250-5mg
|
MedChemexpress LLC
|
PF-998425 [CAS 1076225-27-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-14250-1mL
|
MedChemexpress LLC
|
PF-998425 [CAS 1076225-27-8] (10mM in DMSO)
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-D1509-100mg
|
MedChemexpress LLC
|
Phenazine ethosulfate [CAS 10510-77-7]
|
|
|
|
HY-D1509-25mg
|
MedChemexpress LLC
|
Phenazine ethosulfate [CAS 10510-77-7]
|
|
|
|
HY-D1509-50mg
|
MedChemexpress LLC
|
Phenazine ethosulfate [CAS 10510-77-7]
|
|
|
|
HY-134354A-1mg
|
MedChemexpress LLC
|
pNP-ADPr (disodium)
|
|
|
|
HY-134354A-10mg
|
MedChemexpress LLC
|
pNP-ADPr (disodium)
|
|
|
|
HY-134354A-5mg
|
MedChemexpress LLC
|
pNP-ADPr (disodium)
|
|
|
|
HY-P1797A-10mg
|
MedChemexpress LLC
|
Sakamototide substrate peptide (TFA)
|
|
|
|
HY-P1797A-5mg
|
MedChemexpress LLC
|
Sakamototide substrate peptide (TFA)
|
|
|
|
HY-P1797A-1mL
|
MedChemexpress LLC
|
Sakamototide substrate peptide (TFA) [CAS ] (10mM in DMSO)
|
|
|
|
HY-137742-10mg
|
MedChemexpress LLC
|
SBP-7455 [CAS 1884222-74-5]
|
|
COVID-19-immunoregulation
|
|
HY-137742-100mg
|
MedChemexpress LLC
|
SBP-7455 [CAS 1884222-74-5]
|
|
COVID-19-immunoregulation
|
|
HY-137742-25mg
|
MedChemexpress LLC
|
SBP-7455 [CAS 1884222-74-5]
|
|
COVID-19-immunoregulation
|
|
HY-137742-5mg
|
MedChemexpress LLC
|
SBP-7455 [CAS 1884222-74-5]
|
|
COVID-19-immunoregulation
|
|
HY-137742-50mg
|
MedChemexpress LLC
|
SBP-7455 [CAS 1884222-74-5]
|
|
COVID-19-immunoregulation
|
|
HY-137742-1mL
|
MedChemexpress LLC
|
SBP-7455 [CAS 1884222-74-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-138696-10mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|
HY-138696-100mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|
HY-138696-25mg
|
MedChemexpress LLC
|
Zanzalintinib [CAS 2367004-54-2]
|
|
Cancer-Kinase/protease
|
|